TaiGen Biopharmaceuticals Holdings Competitors and Similar CompaniesClear all
TaiGen Biopharmaceuticals Holdings's competitors and similar companies include Mycenax Biotech, Livzon Pharmaceutical Group, Cipla and Mankind Pharma.
 TaiGen Biopharmaceuticals Holdings TaiGen Biopharmaceuticals Holdings (太景醫藥研發控股股份有限公司) is a company that focuses on the development of therapeutics for diseases such as cancer, infections, and diabetic complications. |  Mycenax Biotech Mycenax Biotech (永昕生物醫藥股份有限公司) is a company that provides biopharmaceutical development services. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines. | |
Founding Date | Founding Date 2005 | Founding Date 2001 | Founding Date 1985 | Founding Date 1935 | Founding Date 1995 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Taipei, TW HQ | Locations Zhunan, TW HQ Taipei, TW Zhunan, TW | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations New Delhi, IN HQ |
Employees | Employees 498% decrease | Employees 387 | Employees 9,067 | Employees 27,764 | Employees 16,2532% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) NT$259.5m (FY, 2025) | Revenue (est.) NT$740.2m (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods NT$18.2m (FY, 2025) | Cost of goods NT$637.3m (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods ₹95.5b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit NT$242.8m (FY, 2025) | Gross profit NT$114.2m (FY, 2025) | Gross profit ¥7.8b (FY, 2025) | Gross profit ₹195b (FY, 2026) | Gross profit N/A |
Net income | Net income NT$45.2m (FY, 2025) | Net income (NT$448.6m) (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income ₹38.7b (FY, 2026) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 75m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 239m |
For sources of this data, please see the company profile
View Company Profiles
Mycenax Biotech
HQ
Zhunan, TW
Employees
387
Mycenax Biotech (永昕生物醫藥股份有限公司) is a company that provides biopharmaceutical development services.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyMankind Pharma
HQ
New Delhi, IN
Employees
16,253↑ 2% increase
Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.
View company